Novo Nordisk’s Wegovy Gets US Approval for Liver Disease - Bloomberg.com

Novo Nordisk A/S’s blockbuster weight-loss drug Wegovy received Food and Drug Administration approval to treat a serious form of liver disease, beating rival Eli Lilly & Co. to the US market for the increasingly prevalent condition.